| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Olmsted Medical Center is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SCRI, an industry leader in clinical trials, is dedicated to advancing therapies for patients through clinical research.
Lovelace Respiratory Research Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lovelace Respiratory Research Institute is based in Albuquerque, NM. You can find more information on Lovelace Respiratory Research Institute at www.lrri.org
Simply Smiles is a Westport, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.